IN2014MU00667A - - Google Patents
Info
- Publication number
- IN2014MU00667A IN2014MU00667A IN667MU2014A IN2014MU00667A IN 2014MU00667 A IN2014MU00667 A IN 2014MU00667A IN 667MU2014 A IN667MU2014 A IN 667MU2014A IN 2014MU00667 A IN2014MU00667 A IN 2014MU00667A
- Authority
- IN
- India
- Prior art keywords
- relates
- transdermal gel
- testosterone
- administering
- pharmaceutically acceptable
- Prior art date
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 2
- 239000003349 gelling agent Substances 0.000 abstract 1
- 239000003961 penetration enhancing agent Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229960003604 testosterone Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/121,269 US20160361321A1 (en) | 2014-02-25 | 2015-02-23 | Stable transdermal testosterone gel |
| PCT/IN2015/000101 WO2015128876A2 (en) | 2014-02-25 | 2015-02-23 | Stable transdermal testosterone gel |
| IN667MU2014 IN2014MU00667A (sr) | 2014-02-25 | 2015-02-23 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN667MU2014 IN2014MU00667A (sr) | 2014-02-25 | 2015-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU00667A true IN2014MU00667A (sr) | 2015-10-23 |
Family
ID=54009732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN667MU2014 IN2014MU00667A (sr) | 2014-02-25 | 2015-02-23 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20160361321A1 (sr) |
| IN (1) | IN2014MU00667A (sr) |
| WO (1) | WO2015128876A2 (sr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
| EP1634583A1 (en) * | 2004-09-09 | 2006-03-15 | Laboratoires Besins International | Testosterone gels comprising propylene glycol as penetration enhancer |
| RS52671B (sr) * | 2005-10-12 | 2013-06-28 | Unimed Pharmaceuticals Llc | Poboljšani gel testosterona i postupak korišćenja |
-
2015
- 2015-02-23 IN IN667MU2014 patent/IN2014MU00667A/en unknown
- 2015-02-23 WO PCT/IN2015/000101 patent/WO2015128876A2/en not_active Ceased
- 2015-02-23 US US15/121,269 patent/US20160361321A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015128876A3 (en) | 2015-11-05 |
| US20160361321A1 (en) | 2016-12-15 |
| WO2015128876A2 (en) | 2015-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258441A (en) | Formulations of pthrp analogues, bandages through their skin and their uses | |
| MX2023000320A (es) | Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion. | |
| MY187540A (en) | Compounds active towards bromodomains | |
| WO2015023649A3 (en) | Peptides for enhancing transdermal delivery | |
| NZ734233A (en) | Pharmaceutical compositions comprising meloxicam | |
| PH12016501790B1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
| PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
| EP3206706A4 (en) | Stable injectable composition of pharmaceutically active agents and process for its preparation | |
| PH12016501788B1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
| IN2014MU00303A (sr) | ||
| MX2019005833A (es) | Administracion transdermica de agentes grandes. | |
| PH12017500239A1 (en) | Abiraterone acetate formulation and methods of use | |
| MX2017011521A (es) | Composiciones topicas que comprenden un corticosteroide. | |
| IN2013MU00711A (sr) | ||
| AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
| UA118474C2 (uk) | (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| EA201691741A1 (ru) | Фармацевтическая композиция | |
| EP3265060A4 (en) | Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent | |
| MX2016005545A (es) | Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo. | |
| PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
| EP3100744A4 (en) | Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation | |
| MX2021003908A (es) | Polipeptidos de accion prolongada y metodos para su produccion y administracion. | |
| PH12017501979A1 (en) | Pharmaceutical compound | |
| EP3100743A4 (en) | Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation | |
| WO2015128876A3 (en) | Stable transdermal testosterone gel |